Navigation Links
ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
Date:7/9/2009

to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for ASMANEX. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A "Risk Factors" in the Company's first quarter 2009 10-Q, filed May 1, 2009.

References:

1. ASMANEX (R) Package Insert. Schering-Plough K.K.

2. ASMANEX (R) U.S. Package Insert. Schering Corporation.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
4. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
5. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
6. Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
7. Angiomax Will Retain Decision Resources Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
8. Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
9. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
10. MGuard(TM) Coronary Stent System Approved in Israel
11. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... VIEW, Calif., Dec. 17 Frost ... 2009 North American Healthcare Innovation Award in ... (IntelligentMDx) for its commitment to providing innovative ... diagnostics. Since its incorporation in 2004, IntelligentMDx ... bioinformatics approach to make tests that are ...
(Date:12/17/2009)... Dec. 17 Decision Resources, one of ... on pharmaceutical and healthcare issues, finds that over ... is a high need for diabetes drugs with ... say there is a high need for additional ... agents with excellent glucose lowering ability and physicians ...
(Date:12/16/2009)... 17 Cell Therapeutics, Inc. (CTI) ... on February 10, 2010 the U.S. Food ... (ODAC) will review the New Drug Application ... relapsed/refractory aggressive non-Hodgkin,s lymphoma (NHL). ODAC is ... data concerning the efficacy and safety of ...
Breaking Medicine Technology:Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 2Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 3Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 4Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics 5Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 2Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4Mars Lends Sweet Support in Fight Against Breast Cancer Through Its M 26amp 3BMs 28R 29 And Dove 28R 29 Chocolate Brands as Well as Its Celebrated Ra 59630 1Mars Lends Sweet Support in Fight Against Breast Cancer Through Its M 26amp 3BMs 28R 29 And Dove 28R 29 Chocolate Brands as Well as Its Celebrated Ra 59630 2Mars Lends Sweet Support in Fight Against Breast Cancer Through Its M 26amp 3BMs 28R 29 And Dove 28R 29 Chocolate Brands as Well as Its Celebrated Ra 59630 3Smart for Life 28TM 29 Center Opens in Ottawa 59627 1Smart for Life 28TM 29 Center Opens in Ottawa 59627 2Haemonetics Sets Date for Second Quarter Fiscal Year 2010 Earnings Release 3A November 2 2009 59624 1
(Date:12/17/2009)... have improved, but Americans fall down on prevention, ... -- While physicians and surgeons are getting better ... too many Americans are ignoring the basic rules ... the American Heart Association. , Topping the list: ... fact, 59 percent of adults surveyed last year ...
(Date:12/17/2009)... results suggest they might be more likely to try ... -- American teens believe that smoking cigarettes is riskier ... government report shows. , That perception may increase the ... the report authors said. , "We are on the ... raising awareness among teens about the dangers of other ...
(Date:12/17/2009)... to access trusted medical information using virtually any smart phone ... ... 17, 2009 -- Skyscape, Inc., the world’s most trusted source ... has launched a mobile clinical decision application on the Google ... on most smart phone devices, making the ability for medical ...
(Date:12/17/2009)... YORK, Dec. 17 Reportlinker.com announces ... available in its catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ... to provide the animal health industry executives ... insight, critical to the development and implementation ... study,s major objectives include: ,, ...
(Date:12/17/2009)... 17 Today, CDC,s Morbidity and Mortality ... the number of state-level epidemiologists has decreased steadily ... 10% since 2006. There was also a substantial ... period, including epidemiology capacity for bioterrorism and emergency ... such as occupational health, substance abuse, and oral ...
Breaking Medicine News(10 mins):Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 3Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 4Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2
... ANSYS, Inc.,(Nasdaq: ANSS ), a global ... product development processes, today announced it is a,sponsor ... the Carnegie Museum of,Natural History in Pittsburgh. This ... feature scientifically accurate, immersive environments that are,composed of ...
... (http://www.NBTY.com ), a leading global manufacturer and marketer ... the,presentation by Harvey Kamil, President and Chief Financial Officer ... Las Vegas on,Wednesday, March 19, 2008., The presentation ... Company Web,site, http://www.nbty.com on Wednesday, March 19, ...
... receptor believed ... in Crohn,s disease -, CAMBRIDGE, Mass., March 17 ... of,MLN3126, a new product candidate, from the Company,s discovery engine ... a,chemokine receptor known to be important in the migration of ...
... in Published Studies Now Available to the ... Posit Science(R) Corporation,today announced the release of ... speeds up and sharpens the brain,s ability ... improves not just visual,processing abilities, but also ...
... Fla., March 17 Researchers will unveil ... has been shown in numerous,published studies to ... improve the performance of daily living tasks ... Science(R) Corporation, a San,Francisco-based neuroscience company, will ...
... research team supported by the National Institutes of ... Allergy and Infectious Diseases (NIAID) has identified chemical ... schistosomiasis, a parasitic disease that afflicts more than ... today in the advance online publication of the ...
Other Medicine News:Health News:ANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural History 2Health News:ANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural History 3Health News:NBTY to Web Cast Presentation at Citigroup Small and Mid-Cap Conference 2Health News:Millennium Expands IBD Franchise with Addition of New Development Candidate 2Health News:Millennium Expands IBD Franchise with Addition of New Development Candidate 3Health News:New Brain Training Program Improves Quality of Life 2Health News:New Brain Training Program Improves Quality of Life 3Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 2Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 3Health News:Scientists identify new leads for treating parasitic worm disease 2Health News:Scientists identify new leads for treating parasitic worm disease 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: